| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 呼吸系统类(元) | 921,205,060.46 | 795,134,832.89 | 1,283,841,035.78 | 3,305,233,950.86 | 3,087,826,306.77 |
| 心脑血管类药(元) | 1,963,438,339.91 | 3,876,277,351.88 | 2,313,825,860.18 | 4,708,693,330.81 | 2,511,312,806.32 |
| 其他(元) | 909,859,444.56 | 1,515,297,119.93 | 846,460,307.40 | 1,868,965,899.49 | 914,846,671.85 |
| 其他专利产品(元) | 245,639,373.01 | 326,025,167.07 | 160,358,613.53 | 435,419,670.32 | 276,575,768.28 |
| 营业成本(元) | |||||
| 呼吸系统类(元) | 268,050,764.06 | 453,437,874.55 | 440,642,562.15 | 1,018,264,950.17 | 981,250,872.49 |
| 心脑血管类药(元) | 676,697,047.57 | 1,662,051,138.92 | 1,092,799,865.20 | 1,960,775,348.65 | 991,309,604.44 |
| 其他(元) | 604,634,049.35 | 978,680,513.44 | 535,953,085.90 | 1,250,594,216.55 | 528,021,806.44 |
| 其他专利产品(元) | 87,627,599.29 | 144,206,373.06 | 77,762,711.59 | 174,924,959.00 | 97,781,508.86 |
| 毛利(元) | |||||
| 呼吸系统类(元) | 653,154,296.40 | 341,696,958.34 | 843,198,473.63 | 2,286,969,000.69 | 2,106,575,434.28 |
| 心脑血管类药(元) | 1,286,741,292.34 | 2,214,226,212.96 | 1,221,025,994.98 | 2,747,917,982.16 | 1,520,003,201.88 |
| 其他(元) | 305,225,395.21 | 536,616,606.49 | 310,507,221.50 | 618,371,682.94 | 386,824,865.41 |
| 其他专利产品(元) | 158,011,773.72 | 181,818,794.01 | 82,595,901.94 | 260,494,711.32 | 178,794,259.42 |
| 毛利率(%) | |||||
| 呼吸系统类(%) | 70.90 | 42.97 | 65.68 | 69.19 | 68.22 |
| 心脑血管类药(%) | 65.54 | 57.12 | 52.77 | 58.36 | 60.53 |
| 其他(%) | 33.55 | 35.41 | 36.68 | 33.09 | 42.28 |
| 其他专利产品(%) | 64.33 | 55.77 | 51.51 | 59.83 | 64.65 |
| 收入构成(%) | |||||
| 呼吸系统类(%) | 22.80 | 12.21 | 27.88 | 32.03 | 45.47 |
| 心脑血管类药(%) | 48.60 | 59.52 | 50.25 | 45.63 | 36.98 |
| 其他(%) | 22.52 | 23.27 | 18.38 | 18.11 | 13.47 |
| 其他专利产品(%) | 6.08 | 5.01 | 3.48 | 4.22 | 4.07 |
| 毛利构成(%) | |||||
| 呼吸系统类(%) | 27.18 | 10.44 | 34.31 | 38.67 | 50.25 |
| 心脑血管类药(%) | 53.54 | 67.62 | 49.69 | 46.47 | 36.26 |
| 其他(%) | 12.70 | 16.39 | 12.64 | 10.46 | 9.23 |
| 其他专利产品(%) | 6.58 | 5.55 | 3.36 | 4.40 | 4.26 |